Trial intelligence / Profile preview

Immunogenicity of PPV23 in JIA Patients Under Anti-TNF Therapy

NCT02196480Phase 4Completed

Sponsor
Universidade de São Paulo
Start
Jan 2008
Primary completion
Jun 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Pneumo 23 in pneumococcal infection, sponsored by Universidade de São Paulo. Started Jan 2008; status: completed.

02

Drugs

Pneumo 23
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT02196480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02196480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call